IL-1β+ macrophages and the control of pathogenic inflammation in cancer
Trends in Immunology · 2025-05 · 46 (5) · 403-415
DOI: 10.1016/j.it.2025.03.001 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Trends in Immunology, 2025-05. Verfasst von Nicoletta Caronni und 3 weiteren Autor:innen. Beteiligte Einrichtung: San Raffaele Telethon Institute for Gene Therapy (SR-Tiget), IRCCS San Raffaele Scientific Institute, Milan, Italy. Electronic address: caronni.nicol…. Hauptthemen laut MEDLINE: Neoplasms, Interleukin-1beta, Inflammation, Macrophages. Die Arbeit wurde bisher 41-mal zitiert (Crossref) und nennt 128 Literaturangaben. Gefördert von: European Research Council, Telethon Foundation, Fondazione AIRC per la ricerca sul cancro ETS.
Abstract (Originalsprache)
While highlighting the complexity and heterogeneity of tumor immune microenvironments, the application of single-cell analyses in human cancers has identified recurrent subsets of tumor-associated macrophages (TAMs). Among these, interleukin (IL)-1β+ TAMs - cells with high levels of expression of inflammatory response and tissue repair genes, but with limited capacity to stimulate cytotoxic immunity - are emerging as key drivers of pathogenic inflammation in cancer. In this review we discuss recent literature defining the phenotypical, molecular, and functional properties of IL-1β+ TAMs, as well as their temporal dynamics and spatial organization. Elucidating the biology of these cells across tumor initiation, progression, metastasis, and therapy could inform the design and interpretation of clinical trials targeting IL-1β and/or other inflammatory factors in cancer immunotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- San Raffaele Telethon Institute for Gene Therapy (SR-Tiget), IRCCS San Raffaele Scientific Institute, Milan, Italy. Electronic address: caronni.nicoletta@hsr.it.
- San Raffaele Telethon Institute for Gene Therapy (SR-Tiget), IRCCS San Raffaele Scientific Institute, Milan, Italy.
- San Raffaele Telethon Institute for Gene Therapy (SR-Tiget), IRCCS San Raffaele Scientific Institute, Milan, Italy; Vita-Salute San Raffaele University, IRCCS San Raffaele Scientific Institute, Milan, Italy.
- San Raffaele Telethon Institute for Gene Therapy (SR-Tiget), IRCCS San Raffaele Scientific Institute, Milan, Italy; Vita-Salute San Raffaele University, IRCCS San Raffaele Scientific Institute, Milan, Italy. Electronic…
Förderung
- European Research Council
- Telethon Foundation
- Fondazione AIRC per la ricerca sul cancro ETS
- American Association for Cancer Research
- Ministry of Health
- Fondazione Umberto Veronesi
- FP7 Ideas: European Research Council
- Associazione Italiana per la Ricerca sul Cancro
Zitieren
APA
Caronni, N., La Terza, F., Frosio, L., & Ostuni, R. (2025). IL-1β+ macrophages and the control of pathogenic inflammation in cancer. Trends in Immunology, 46(5), 403-415. https://doi.org/10.1016/j.it.2025.03.001
Vancouver
Caronni N, La Terza F, Frosio L, Ostuni R. IL-1β+ macrophages and the control of pathogenic inflammation in cancer. Trends in Immunology. 2025;46(5):403-415. doi:10.1016/j.it.2025.03.001
BibTeX
@article{Caronni2025,
author = {Caronni, Nicoletta and La Terza, Federica and Frosio, Luca and Ostuni, Renato},
title = {IL-1β+ macrophages and the control of pathogenic inflammation in cancer},
journal = {Trends in Immunology},
year = {2025},
volume = {46},
number = {5},
pages = {403--415},
doi = {10.1016/j.it.2025.03.001}
}
EUVIMED